Sathgen Therapeutics announces completion of first cohort in phase 1 clinical trial with anti-cancer drug Read more
Transgender inclusion in healthcare: Breaking barriers and creating equitable clinical trials Read more
Lupin receives USD 25 million from AbbVie for successful initiation of Phase 1 clinical studies Read more
Neuralink, Elon Musk’s brain-implant company, announces US FDA approval for clinical trials Read more
Rakuten Medical to start phase 3 trial of Alluminox treatment using ASP-1929 for head and neck cancer Read more
US FDA asks Sun Pharma to stop trial on dermatological drug citing potential of blood clots Read more
